Provided by Tiger Trade Technology Pte. Ltd.

Bank of America

52.55
+0.03000.06%
Post-market: 52.590.0400+0.08%19:59 EST
Volume:31.77M
Turnover:1.66B
Market Cap:378.99B
PE:13.79
High:52.82
Open:51.91
Low:51.44
Close:52.52
52wk High:57.55
52wk Low:33.07
Shares:7.21B
Float Shares:6.71B
Volume Ratio:0.70
T/O Rate:0.47%
Dividend:1.08
Dividend Rate:2.06%
EPS(TTM):3.81
EPS(LYR):3.81
ROE:10.19%
ROA:0.91%
PB:1.37
PE(LYR):13.79

Loading ...

Telefonica Brasil (VIV) Receives a Sell from Bank of America Securities

TIPRANKS
·
1 hour ago

Class Action Over Epstein Ties Puts Bank Of America Valuation In Focus

Simply Wall St.
·
Yesterday

Bank of America Securities Reaffirms Their Buy Rating on Budweiser Brewing Co. APAC Ltd. (1876)

TIPRANKS
·
Yesterday

Bank of America (BAC) Raises CEO Moynihan’s Compensation 17% to $41 Million

TIPRANKS
·
Yesterday

Bank of America Raises CEO Moynihan’s 2025 Compensation

TIPRANKS
·
Yesterday

BofA CEO Brian Moynihan's pay rises to $41 million

Reuters
·
Yesterday

Bank of America Corp - CEO Brian Moynihan Compensation $41 Mln for 2025 - SEC Filing

THOMSON REUTERS
·
Yesterday

US Equity Indexes Fall This Week as AI-Scare Trade, Fed Policy Pause Expectations Keep Bulls at Bay

MT Newswires Live
·
Yesterday

Emerson Electric Secures $2 Billion Unsecured 364-Day Credit Facility

Reuters
·
Yesterday

LIVE MARKETS-A new era for industrials?

Reuters
·
Yesterday

Berkshire Might Have Sold More Apple, Bank of America Stock in Fourth Quarter -- Barrons.com

Dow Jones
·
Yesterday

Bank of America (BAC) Says U.S. Treasuries Are the Best ‘Safe Haven’ for Investors

TIPRANKS
·
Yesterday

Agree Realty Corporation Publishes Transcript of Fourth Quarter 2025 Earnings Call

Reuters
·
Feb 13

Bank of America Securities Sticks to Their Buy Rating for Anheuser-Busch Inbev Sa (BUD)

TIPRANKS
·
Feb 13

Why Bank of America says 30-year Treasurys are the best hedge for investors

Dow Jones
·
Feb 13

Bank of America Securities Sticks to Their Buy Rating for JFrog (FROG)

TIPRANKS
·
Feb 13

Balanced Risk‑Reward Keeps Rating at Hold as Core Focus and Margin Improvements Remain Longer‑Term Drivers

TIPRANKS
·
Feb 13

Sell Recommendation on Optimum Driven by Persistent Revenue Erosion, Execution Risks, and Unsustainable Leverage

TIPRANKS
·
Feb 13

Neutral on 10x Genomics: Solid Competitive Position but Cautious Spending and Unclear Growth Keep Rating at Hold

TIPRANKS
·
Feb 13

Global Rebalancing Heats Up as Investors Shift Away from U.S. Assets

Stock News
·
Feb 13